The European LeukemiaNet AML Working Party consensus statement on allogeneic HSCT for patients with AML in remission: an integrated-risk adapted approach

Details 詳細情報について

• CRID

  1363670318815329920

• DOI

  10.1038/nrclinonc.2012.150

• ISSN

  17594782

  17594774

• Web Site

  http://www.nature.com/articles/nrclinonc.2012.150.pdf

  http://www.nature.com/articles/nrclinonc.2012.150

• Data Source

  • Crossref